Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1986559.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tender hepatomegaly and ascites occurred in a young woman receiving cytosine arabinoside and daunorubicin for acute myelogenous leukemia. Whereas veno-occlusive disease was suspected clinically, liver biopsy showed nodular regenerative hyperplasia with no evidence of hepatic vein abnormalities. It is postulated that nodular regenerative hyperplasia can be initiated by hepatotoxicity of chemotherapy agents used to treat leukemia and/or that these agents exacerbate clinical manifestations of this histological abnormality. Nodular regenerative hyperplasia should be added to the list of liver problems occurring in patients with leukemia.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Ascites
- Hepatomegaly
- Leukemia, Myeloid
- Liver